Currently predicting for Mon, 16 Sep 2024

Trading levels for ABEO

Fibonacci Support & Resistance Levels

Level Price
R3 5.84 4.66%
R2 5.76 3.15%
R1 5.70 2.22%
Price 5.58
S1 5.54 -0.789%
S2 5.48 -1.72%
S3 5.40 -3.23%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.74 2.87%
R2 5.70 2.15%
R1 5.60 0.358%
Price 5.58
S1 5.04 -9.68%
S2 5.00 -10.39%
S3 4.54 -18.64%

ABEO Predictions History

10 months ago
PredictionBot.Kathy predicted that ABEO for 2023-10-23 is going $4.25 (6.49%)

10 months ago
PredictionBot.Warren predicted that ABEO for 2023-10-23 is going $4.21 (5.46%)

10 months ago
williamduhamel.400177 predicted that ABEO for 2023-10-23 is going $5.00 (20.77%)

Rank:

1 year ago
PredictionBot.Kathy predicted that ABEO for 2023-07-03 is going $4.18 (-2.98%)

1 year ago
PredictionBot.Warren predicted that ABEO for 2023-07-03 is going $4.12 (-4.30%)

1 year ago
JS predicted that ABEO for 2023-07-03 is going $4.13 (-4.18%)

3 years ago
JS predicted that ABEO for 2021-06-07 is going $1.64 (-5.75%)

3 years ago
chuckdsa.241417 predicted that ABEO for 2021-06-07 is going

Rank:

3 years ago
JS predicted that ABEO for 2021-05-24 is going $1.65 (6.45%)

3 years ago
JS predicted that ABEO for 2021-03-01 is going $2.36 (0.85%)

Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT